158 related articles for article (PubMed ID: 8944350)
1. Nonpigmenting fixed drug eruption: a new case due to betahistine.
Dereure O; Guilhou JJ
Dermatology; 1996; 193(3):248-50. PubMed ID: 8944350
[TBL] [Abstract][Full Text] [Related]
2. Betahistine: hallucinations?
Prescrire Int; 2015 Nov; 24(165):269. PubMed ID: 26688903
[No Abstract] [Full Text] [Related]
3. Nonpigmenting fixed drug eruption due to pseudoephedrine.
Vidal C; Prieto A; Pérez-Carral C; Armisén M
Ann Allergy Asthma Immunol; 1998 Apr; 80(4):309-10. PubMed ID: 9564979
[TBL] [Abstract][Full Text] [Related]
4. Pseudoephedrine may cause "pigmenting" fixed drug eruption.
Ozkaya E; Elinç-Aslan MS
Dermatitis; 2011 May; 22(3):E7-9. PubMed ID: 21569741
[TBL] [Abstract][Full Text] [Related]
5. Symmetric ptychotropic and nonpigmenting fixed drug eruption due to cimetidine (so-called baboon syndrome).
Helmbold P; Hegemann B; Dickert C; Marsch WC
Dermatology; 1998; 197(4):402-3. PubMed ID: 9873190
[No Abstract] [Full Text] [Related]
6. Nonpigmenting and pigmenting fixed drug eruptions due to clarithromycin.
Asano A; Sowa-Osako J; Umekoji-Hayashi A; Teramae A; Fukai K; Tsuruta D
Contact Dermatitis; 2021 Nov; 85(5):590-591. PubMed ID: 34129244
[No Abstract] [Full Text] [Related]
7. Transient, nonpigmenting fixed drug eruption caused by radiopaque contrast media.
Benson PM; Giblin WJ; Douglas DM
J Am Acad Dermatol; 1990 Aug; 23(2 Pt 2):379-81. PubMed ID: 2144305
[TBL] [Abstract][Full Text] [Related]
8. Nonpigmenting fixed drug eruption after pseudoephedrine.
Quan MB; Chow WC
Int J Dermatol; 1996 May; 35(5):367-70. PubMed ID: 8734664
[No Abstract] [Full Text] [Related]
9. An elderly female patient with tardive oromandibular dystonia after prolonged use of the histamine analog betahistine.
De Riu G; Sanna MP; De Riu PL
J Clin Neurosci; 2010 Oct; 17(10):1330-1. PubMed ID: 20594853
[TBL] [Abstract][Full Text] [Related]
10. [Fixed drug eruption induced by sulfaguanidine].
Kastalli S; El Aidli S; Daghfous R; Trabelsi S; Lakhal M; Loueslati MH; Belkahia C
Ann Dermatol Venereol; 2004 Apr; 131(4):382-4. PubMed ID: 15258515
[TBL] [Abstract][Full Text] [Related]
11. Fixed drug eruptions. Incidence, recognition, and avoidance.
Lee AY
Am J Clin Dermatol; 2000; 1(5):277-85. PubMed ID: 11702319
[TBL] [Abstract][Full Text] [Related]
12. Non-pigmenting fixed drug eruption: a new case due to eperisone hydrochloride.
Choonhakarn C
Br J Dermatol; 2001 Jun; 144(6):1288-9. PubMed ID: 11422074
[No Abstract] [Full Text] [Related]
13. A localized, recurrent pustular eruption following amoxycillin administration.
Shuttleworth D
Clin Exp Dermatol; 1989 Sep; 14(5):367-8. PubMed ID: 2532988
[TBL] [Abstract][Full Text] [Related]
14. Nonpigmenting solitary fixed drug eruption caused by a Chinese traditional herbal medicine, ma huang (Ephedra Hebra), mainly containing pseudoephedrine and ephedrine.
Matsumoto K; Mikoshiba H; Saida T
J Am Acad Dermatol; 2003 Apr; 48(4):628-30. PubMed ID: 12664035
[TBL] [Abstract][Full Text] [Related]
15. Non-pigmenting fixed drug eruption induced by sorafenib.
Tanabe K; Amoh Y; Mii S; Eto H; Iwamura M; Katsuoka K
Acta Derm Venereol; 2010 May; 90(3):307. PubMed ID: 20526556
[No Abstract] [Full Text] [Related]
16. [Fixed pigmented erythema antihistamine H1: about 2 cases and review of the literature].
Lakhoua G; El Aidli S; Zaïem A; Sahnoun R; Kastalli S; Hedi Loueslati M; Daghfous R
Therapie; 2014; 69(3):243-4. PubMed ID: 24934820
[TBL] [Abstract][Full Text] [Related]
17. Nonpigmenting fixed drug eruption as a distinctive reaction pattern: examples caused by sensitivity to pseudoephedrine hydrochloride and tetrahydrozoline.
Shelley WB; Shelley ED
J Am Acad Dermatol; 1987 Sep; 17(3):403-7. PubMed ID: 2958519
[TBL] [Abstract][Full Text] [Related]
18. [Delirium in a 73-year-old man after many years of unwise use of betahistine].
Hoenders HJ; Wilterdink J
Ned Tijdschr Geneeskd; 2004 Nov; 148(47):2338-41. PubMed ID: 15587054
[TBL] [Abstract][Full Text] [Related]
19. Reticulated multifocal fixed drug eruption due to mefenamic acid - a new morphological pattern.
Dar NR; Masood S; Mustafvi SA
J Coll Physicians Surg Pak; 2005 Sep; 15(9):562-3. PubMed ID: 16181578
[TBL] [Abstract][Full Text] [Related]
20. Pregnancy outcomes after maternal betahistine exposure: A case series.
Buharalioglu CK; Acar S; Erol-Coskun H; Küçüksolak G; Karadas B; Kaya-Temiz T; Kaplan YC
Reprod Toxicol; 2018 Aug; 79():79-83. PubMed ID: 29908288
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
